CCIA
RDY icon

Campbell & Co Investment Adviser’s Dr. Reddy's Laboratories RDY Stock Holding History

Campbell & Co Investment Adviser’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
+10,599
New +$143K 0.01% 991
2025
Q4 		– Sell
-49,017
Closed -$685K – 1361
2025
Q3 		$685K Sell
49,017
-96,860
-66% -$1.39M 0.05% 582
2025
Q2 		$2.19M Buy
+145,877
New +$2.08M 0.14% 226
2024
Q4 		– Sell
-55,130
Closed -$876K – 1309
2024
Q3 		$876K Buy
55,130
+38,215
+226% +$615K 0.07% 484
2024
Q2 		$258K Sell
16,915
-22,735
-57% -$326K 0.02% 888
2024
Q1 		$582K Buy
+39,650
New +$579K 0.05% 631
2023
Q4 		– Sell
-65,245
Closed -$873K – 1297
2023
Q3 		$873K Buy
+65,245
New +$883K 0.1% 314
2022
Q2 		– Sell
-18,610
Closed -$207K – 876
2022
Q1 		$207K Buy
+18,610
New +$211K 0.06% 622
2020
Q3 		– Sell
-19,725
Closed -$209K – 462
2020
Q2 		$209K Buy
+19,725
New +$201K 0.26% 207
2018
Q3 		– Sell
-62,645
Closed -$403K – 504
2018
Q2 		$403K Buy
+62,645
New +$395K 0.31% 107
2018
Q1 		– Sell
-43,185
Closed -$324K – 507
2017
Q4 		$324K Buy
+43,185
New +$311K 0.24% 159
2013
Q4 		– Sell
-162,105
Closed -$1.23M – 292
2013
Q3 		$1.23M Buy
+162,105
New +$1.18M 0.24% 125

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Campbell & Co Investment Adviser's RDY Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 10,599 shares worth $154K. The stake represents 0.01% of the portfolio and ranks #991 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in RDY as recently as Q3 2025.

Campbell & Co Investment Adviser first reported a position in RDY in Q3 2013 and has held it in 12 quarters since. The position peaked at $2.19M in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Campbell & Co Investment Adviser held 10,599 shares of Dr. Reddy's Laboratories worth $154K as of Q2 2026.
  • Dr. Reddy's Laboratories was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.01% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #991 holding.
  • Campbell & Co Investment Adviser first reported a position in Dr. Reddy's Laboratories in Q3 2013 and has held it in 12 quarters since.
  • Campbell & Co Investment Adviser's Dr. Reddy's Laboratories position peaked at $2.19M in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.